Diagnosis and thermal ablation of papillary thyroid microcarcinoma

doi:10.16352/j.issn.1001-6325.2024.12.1722

Abstract

Abstract: Papillary thyroid microcarcinoma may develop cervical lymph node metastasis, which is especially important for early diagnosis, evaluation and treatment of PTMC. High-frequency ultrasound, ultrasonography, ultrasound-guided fine-needle aspiration biopsy, and genetic testing have been applied to the diagnosis of PTMC, which has continuously improved the detection rate of PTMC. In recent years, thermal ablation has been applied to the treatment of tumors due to its advantages of safety, high efficiency, low trauma and fast post-operative recovery and has achieved good results.

Key words: papillary thyroid micro-carcinoma, diagnosis, minimally invasive treatment

CLC Number:

QUAN Yinglan, LI Ning. Diagnosis and thermal ablation of papillary thyroid microcarcinoma[J]. Basic & Clinical Medicine, 2024, 44(12): 1722-1726.

References

[1]Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71:209-249.
[2]Pizzato M, Li M, Vignat J, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020[J]. Lancet Diabetes Endocrinol,2022,10:264-272.
[3]Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States[J]. Cancer Res, 2014,74:2913-2921.
[4]Fagin JA,Wells SA Jr.Biologic and clinical perspectives on thyroid cancer[J].N Engl J Med,2016,375:2307.doi:10.1056/NEJMc1613118.
[5]Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid,2016,26:1-133.
[6]Ruan J, Xu X, Cai Y, et al. A practical CEUS thyroid reporting system for thyroid nodules[J]. Radiology,2022,305:149-159.
[7]Haddad RI, Bischoff L, Ball D, et al. Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw,2022,20:925-951.
[8]Xu H, Zhang Y, Wu H, et al. High diagnostic accuracy of epigenetic imprinting biomarkers in thyroid nodules[J]. J Clin Oncol,2023,41:1296-1306.
[9]Lu C, Li X, Chu X,et al. Clinical effects of microwave ablation in the treatment of low-risk papillary thyroid microcarcinomas and related histopathological changes[J].Front Endocrinol (Lausanne),2021,12:751213.doi:10.3389/fendo.2021.751213.
[10]Ma B, Wei W, Xu W, et al. Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: a retrospective case review and literature review[J]. Thyroid, 2018,28:1134-1142.
[11]Baldwin CK, Natter MB, Patel KN,et al. Minimally invasive techniques for the management of thyroid nodules[J].Endocrinol Metab Clin North Am,2022,51:323-349.
[12]朱晨芳,陈江波,林庭伃,等.热消融技术治疗甲状腺良、恶性肿瘤的现状与展望[J].外科研究与新技术,2022,11:221-226.
[13]Ahmed M,Brace CL,Lee FT Jr,et al.Principles of and advances in percutaneous ablation[J].Radiology,2011,258:351-369.
[14]Yan L, Lan Y, Xiao J, et al. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients[J]. Eur Radiol, 2021,31:685-694.
[15]He H, Song Q, Lan Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma in patients aged 55 years or older: a retrospective study[J]. Int J Hyperthermia, 2021,38:604-610.
[16]Yan L, Zhang M, Song Q, et al. The efficacy and safety of radiofrequency ablation for bilateral papillary thyroid microcarcinoma[J].Front Endocrinol(Lausanne),2021,12:663636.doi:10.3389/fendo.2021.663636.
[17]Zaltieri M, Massaroni C, Cauti FM, et al. Techniques for temperature monitoring of myocardial tissue undergoing radiofrequency ablation treatments: an overview[J]. Sensors (Basel),2021,21:1453. doi: 10.3390/s21041453.
[18]Yong-Ping L, Juan Z, Li JW, et al.The value of ultrasound guided laser ablation in papillary thyroid recurrence carcinoma: a retrospective, single center study from China[J]. Front Endocrinol (Lausanne), 2022,13:946966.doi: 10.3389/fendo.2022.946966.
[19]Juan Z, Yongping L, Han X, et al. A 5-year follow-up study on the efficacy and safety of ultrasound-guided laser ablation in elderly patients with papillary thyroid microcarcinoma: a retrospective, single-center study from China[J]. Front Endocrinol (Lausanne), 2022,13:972589.doi:10.3389/fendo.2022.972589.
[20]Zhang L, Zhang GP, Zhan WW, et al. The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma[J].Front Endocrinol(Lausanne),2022,13:921812.doi:10.3389/fendo.2022.921812.
[21]Kim C. Understanding the nuances of microwave ablation for more accurate post-treatment assessment[J]. Future Oncol,2018,14:1755-1764.
[22]Zhou W, Jiang S, Zhan W, et al. Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: preliminary results[J]. Eur Radiol, 2017,27:2934-2940.
[23]Teng DK, Li HQ, Sui GQ, et al. Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study[J]. Endocrine, 2019,64:109-117.
[24]Yu XY, Zhou HD, Wei Y, et al. Preliminary study of microwave ablation for multifocal papillary thyroid microcarcinoma in nonoperative candidates[J]. J Vasc Interv Radiol,2023,34:999-1006.